Navigation Links
Positive Opinion, Stock Price Movement, and Executive Appointments - Research Report on Celgene, Sirona, Centene, Fresenius Medical Care, and PerkinElmer
Date:11/28/2013

dge and strong track record of building and growing successful global businesses will enable him to play a pivotal role in helping PerkinElmer accelerate growth and innovation." PerkinElmer further added that Maurice "Dusty" Tenney, who has led the Environmental Health business for four years, will transition to a newly created position overseeing global operations and customer logistics for the Corporation. The Full Research Report on PerkinElmer, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/2016_PKI

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE'/>"/>

SOURCE Analysts' Corner
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
2. Advance Recruitment Delighted With Positive Outlook for Medical Device Sales Industry
3. Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance
4. Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial
5. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
6. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
7. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
8. Scioderm Announces Positive Phase II Data of Topical SD-101 on Wound Closure and Reduction of Lesions and Blisters in Children with Epidermolysis Bullosa (EB)
9. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
10. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
11. Access Pharmaceuticals Announces Positive Data From MuGard Phase 4 Clinical Trial In Oral Mucositis At MASCC/ISOO 2012 Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 Reportlinker.com announces that ... in its catalogue: Wireless Opportunities ... Zigbee, UWB WWAN, WMAN, WLAN and other ... Kalorama Information,s Wireless Opportunities in ... UWB WWAN, WMAN, WLAN and other technologies) ...
(Date:8/20/2014)... , Aug. 20, 2014   Ventana ... Roche  Group, today announced that its VENTANA System ... marked in the European Union for routine pathology, ... system, consisting of VENTANA Virtuoso software coupled with ... iScan HT slide scanner, provides automated digital slide ...
(Date:8/20/2014)... Aug. 20, 2014  Decision Resources Group ... and ablation device market will expand through ... treat atrial fibrillation (AF). The increasing acceptance ... for AF will spur adoption of premium-priced ... as advanced loop diagnostic catheters, cryoablation catheters ...
Breaking Medicine Technology:Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 2Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 3Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 4Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 5Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 6Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 7Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 8Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 9Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 10Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 11Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 12Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 13Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 14Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 15Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 16Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 2Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 3
... Dec. 8 Halozyme Therapeutics, Inc.,(Nasdaq: HALO ... extracellular matrix, today announced that Roche has,dosed the first ... a,subcutaneous formulation using Enhanze Technology of a biologic directed ... payment under the,agreement. , ...
... Positive Opinion for TEMODAL(R) Intravenous Formulation and Oral TEMODAL ... EU Patients with Certain Primary Brain Tumors , ... Schering-Plough Corporation (NYSE: SGP ) today ... Use (CHMP) of the European Medicines Agency (EMEA) has ...
Cached Medicine Technology:Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target 2Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target 3Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target 4CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors 2CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors 3CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors 4CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors 5CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors 6
(Date:8/20/2014)... The non-small cell lung cancer (NSCLC) ... offing across the top 8 developed nations, from just ... USD 8 billion by 2020-end, posting a CAGR of ... to be driven by innovative therapies entering the squamous ... treatment, unlike the non-squamous segment. Thus, patients with SCC ...
(Date:8/20/2014)... Santa Rosa, CA (PRWEB) August 20, 2014 ... is the 12 per diode panel band perfect spectrum that ... plants are most likely to use during photosynthesis. A ... spectral bands is that they almost exclusively reside between 440-480 ... 620-680 on the red side of the spectrum. The KIND ...
(Date:8/20/2014)... Battle Creek, MI (PRWEB) August 20, 2014 ... an open-ended drug and alcohol treatment program that gets clients ... foundation in recovery they can believe in, is highlighting an ... that must be heeded by everyone who wants to understand ... “Many people are of the belief that drug abuse targets ...
(Date:8/20/2014)... 20, 2014 According to a ... "Multiplexed Diagnostics Market (Technologies: Very High, High, Medium, ... Disease Diagnosis, Oncology, Autoimmune Diseases, Cardiac, Allergies and ... Trends and Forecast, 2013 - 2019", the global ... billion in 2012 and is expected to grow ...
(Date:8/20/2014)... A survey of U.S. veterans receiving mental health services ... also significant room for improvement among all areas studied. ... 2009, found that patients with a substance use disorder ... health services. Those with substance abuse problems also were ... to them or respected their decisions. , The findings, ...
Breaking Medicine News(10 mins):Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 2Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 3Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 4Health News:Cheap LED Grow Lights Are Quickly Being Replaced by Premium Grow Lights 2Health News:New A Forever Recovery Blog Post Reminds People that Drug Abuse Doesn’t Discriminate 2Health News:New A Forever Recovery Blog Post Reminds People that Drug Abuse Doesn’t Discriminate 3Health News:Multiplexed Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Multiplexed Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Multiplexed Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:Survey finds veterans generally satisfied with mental health care 2
... for 2009VANCOUVER, Feb. 19 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: ... reported its financial results for the fourth quarter ending December ... its guidance for 2009. Unless specified otherwise, all amounts are ... "2008 was a pivotal year for us as we concluded ...
... Defyrus Inc. today announced the signing an exclusive, ... the United Kingdom,s Defence Science and Technology Laboratory ... commercialization company. These patents form the intellectual property ... Defyrus and Ploughshare Innovation Ltd plan to expand ...
... Advisers, LLC (MCRA), the leading musculoskeletal consulting firm ... and reimbursement strategy development, announced today the signing ... to have reached this important milestone in the ... date are directly attributed to our best-in-class team ...
... continuing operations of $0.70, [excluding amortization], up 19.8% ... $0.65, up 18.3% - Net revenues of $24.1 ... (NYSE: CVS ), today announced record ... quarter and year ended December 31, 2008. (Logo: ...
... 2009 OutlookVIRGINIA BEACH, Va., Feb. 19, 2009 AMERIGROUP Corporation ... income for the fourth quarter of 2008 increased 20.0% to ... of $31.1 million, or $0.57 per diluted share, for the ... 31, 2008, the Company,s net loss was $50.7 million, or ...
... Free 6-Month Subscription to its Vulnerability Management and Endpoint Protection ... and Reduce TCO , ... Scottsdale, ... leader in security management, announced the launch of its global ...
Cached Medicine News:Health News:QLT Announces Fourth Quarter and Year End 2008 Results 2Health News:QLT Announces Fourth Quarter and Year End 2008 Results 3Health News:QLT Announces Fourth Quarter and Year End 2008 Results 4Health News:QLT Announces Fourth Quarter and Year End 2008 Results 5Health News:QLT Announces Fourth Quarter and Year End 2008 Results 6Health News:QLT Announces Fourth Quarter and Year End 2008 Results 7Health News:QLT Announces Fourth Quarter and Year End 2008 Results 8Health News:QLT Announces Fourth Quarter and Year End 2008 Results 9Health News:QLT Announces Fourth Quarter and Year End 2008 Results 10Health News:QLT Announces Fourth Quarter and Year End 2008 Results 11Health News:QLT Announces Fourth Quarter and Year End 2008 Results 12Health News:QLT Announces Fourth Quarter and Year End 2008 Results 13Health News:QLT Announces Fourth Quarter and Year End 2008 Results 14Health News:QLT Announces Fourth Quarter and Year End 2008 Results 15Health News:QLT Announces Fourth Quarter and Year End 2008 Results 16Health News:QLT Announces Fourth Quarter and Year End 2008 Results 17Health News:QLT Announces Fourth Quarter and Year End 2008 Results 18Health News:QLT Announces Fourth Quarter and Year End 2008 Results 19Health News:Vaccine patent portfolio licensed from UK Ministry of Defence 2Health News:Musculoskeletal Clinical Regulatory Advisers, LLC Announces Signing of its 100th Client 2Health News:CVS Caremark Reports Record Results in Fourth Quarter and Year 2008 2Health News:CVS Caremark Reports Record Results in Fourth Quarter and Year 2008 3Health News:CVS Caremark Reports Record Results in Fourth Quarter and Year 2008 4Health News:CVS Caremark Reports Record Results in Fourth Quarter and Year 2008 5Health News:CVS Caremark Reports Record Results in Fourth Quarter and Year 2008 6Health News:CVS Caremark Reports Record Results in Fourth Quarter and Year 2008 7Health News:CVS Caremark Reports Record Results in Fourth Quarter and Year 2008 8Health News:CVS Caremark Reports Record Results in Fourth Quarter and Year 2008 9Health News:CVS Caremark Reports Record Results in Fourth Quarter and Year 2008 10Health News:CVS Caremark Reports Record Results in Fourth Quarter and Year 2008 11Health News:CVS Caremark Reports Record Results in Fourth Quarter and Year 2008 12Health News:CVS Caremark Reports Record Results in Fourth Quarter and Year 2008 13Health News:CVS Caremark Reports Record Results in Fourth Quarter and Year 2008 14Health News:CVS Caremark Reports Record Results in Fourth Quarter and Year 2008 15Health News:CVS Caremark Reports Record Results in Fourth Quarter and Year 2008 16
... Calvin Klein Collection. Provocatively inspired for ... a bold outlook. Innovative structure: soft-sculpted ... technology enhances modern design. Technological sophistication ... enhance the face., ,The Calvin Klein ...
... Marc Jacobs is ... very first collection in ... unveiling a range of ... that are defined by ...
... new GUCCI DONNA eyewear collection celebrates the ... a vintage yet contemporary feel, the unmistakable ... new GUCCI UOMO optical and sunglass collection, ... classic lines with cutting-edge design that is ...
The Alexander McQueen eyewear collection focuses on a distinctive sophisticated style, with feminine lines, assertive shapes and original silhouettes....
Medicine Products: